Blog summary of a research paper published by Aging (Aging-US) in Volume 15, Issue 8: "Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics – an AI-enabled biological target discovery platform.”_____________________________________________________Glioblastoma multiforme (GBM) is one of the most aggressive and fatal malignant brain tumors. With a median survival time of 15 months, only about 25% of patients survive for one year and less than 5% survive for five years. As people get older, the risk of developing GBM increases. The discovery of new drug targets for GBM is of paramount importance.The good news here is that high school students, Zachary Harpaz, Andrea Olsen and Christopher Ren, and researchers Anastasia Shneyderman, Alexander Veviorskiy, Maria Dralkina, Simon Konnov, Olga Shcheglova, Frank W. Pun, Geoffrey Ho Duen Leung, Hoi Wing Leung, Ivan V. Ozerov, Alex Aliper, Mikhail Korzinkin, and Alex Zhavoronkov have recently made remarkable strides in the joint field of aging and glioblastoma research. The team used a generative artificial intelligence (AI) engine from Insilico Medicine (founded by Dr. Alex Zhavoronkov) called PandaOmics, to identify new therapeutic targets for both GBM and aging. On April 26, 2023, their research paper was published in Aging’s Volume 15, Issue 8, entitled, “Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics – an AI-enabled biological target discovery platform.”Full blog - https://aging-us.org/2023/05/high-school-students-use-ai-to-make-aging-and-glioblastoma-discoveries/Research paper DOI - https://doi.org/10.18632/aging.204678Corresponding author - Mikhail Korzinkin - mike@insilicomedicine.comSign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204678Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alertsKeywords - aging, target discovery, GBM, glioblastoma, PandaOmicsAbout Aging-USLaunched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.Please visit our website at https://www.Aging-US.com and connect with us:SoundCloud - https://soundcloud.com/Aging-UsFacebook - https://www.facebook.com/AgingUS/Twitter - https://twitter.com/AgingJrnlInstagram - https://www.instagram.com/agingjrnl/YouTube - https://www.youtube.com/@AgingJournalLinkedIn - https://www.linkedin.com/company/aging/Pinterest - https://www.pinterest.com/AgingUS/Media Contact18009220957MEDIA@IMPACTJOURNALS.COM